No Data
Cacco Narrows Quarterly Loss but Maintains Full-Year Loss Outlook and No Dividend
Cacco 1Q Parent Loss Y23.00M Vs Loss Y32.00M
Stocks that moved or traded actively in the morning session.
*Sakai Chemical Industry <4078> 5,640 yen — continues to gain upward momentum as an MLCC materials-related stock. *Nihon Dempa Kogyo <6779> 3,895 yen (+700) — sustained optimism over rising demand for crystal oscillators for AI applications. *TerraSky <3915> 2,477 yen (+414) — jointly developing new material simulation technology on quantum computers with Mitsui Mining & Smelting. *Noritake <5331> 4,635 yen (+700) — attracting investor interest as a laggard in the MLCC-related segment. *FIG <4392> 2,057 yen (+2,764) — capable of continuous flight for 48 hours.*
Aftermarket [stocks that moved / stocks that traded]
*PAR HD <2726> 1,394 (+19): Announced a share buyback up to 0.57% of outstanding shares. Upside appears limited. *Nihon Plastic Co., Ltd. <7291> 474 (+10): Announced a share buyback and purchase委托 (buying mandate) up to 0.40% of outstanding shares, with full acquisition completed today. Upside remains constrained. *Planet Inc. <2391> 1,209 (−29): Reported a 1.5% year-on-year decline in operating profit for the cumulative nine-month period, shifting from a 10.7% increase in the first half to a decline. *Inpex <1605> 3,693 (+4): Gained in the afternoon session on rising crude oil prices.
Stocks hitting upper or lower price limits in the afternoon session.
■Limit Up: <3905> Datasection <4100> Toda Kogyo <4166> KAKKO <5367> Nikka Toh <6203> Howa Machinery <6327> Kitagawa Seiki <6977> Nihon Rakkisho Seisakusho <7435> NADEX <7501> TIMCO <7794> EDP <8105> Bitcoin Japan <9348> ispace ■Limit Down: <3558> Jade Group <5031> MOI <6085> Architects Studio Japan
Spider-Plus, Oncoris Bio, and others
<4166> Kako Information has entered into a share transfer agreement to acquire shares of Anycloud, an information services company. <4192> Spider Plus has entered into a capital and business alliance agreement with Infomart. <2492> Oncolys Bio has received a notice of allowance from the European Patent Office for a patent related to endoscopic administration of its oncolytic virus OBP-301 in Europe. <4883> Modalis has issued its 19th series of stock acquisition rights (with exercise price adjustment provisions), representing up to 24 million potential shares and raising approximately JPY 13.31 billion.